-
Potential Role for YB-1 in Castration-Resistant Prostate Cancer and Resistance to Enzalutamide Through the Androgen Receptor
V7
Masaki Shiota, Naohiro Fujimoto, Kenjiro Imada, Akira Yokomizo, Momoe Itsumi, Ario Takeuchi, Hidetoshi Kuruma, Junichi Inokuchi,
Katsunori Tatsugami, Takeshi Uchiumi, Yoshinao Oda, and Seiji Naito
Journal of the National Cancer Institute
(2016)
108 :djw005
-
Antioxidant Therapy Alleviates Oxidative Stress by Androgen Deprivation and Prevents Conversion From Androgen Dependent to
Castration Resistant Prostate Cancer
Masaki Shiota, YooHyun Song, Ario Takeuchi, Akira Yokomizo, Eiji Kashiwagi, Kentaro Kuroiwa, Katsunori Tatsugami, Takeshi
Uchiumi, Yoshinao Oda, and Seiji Naito
The Journal of Urology
(2012)
187 :707
-
SRD5A gene polymorphism in Japanese men predicts prognosis of metastatic prostate cancer with androgen-deprivation therapy
Masaki Shiota, Naohiro Fujimoto, Akira Yokomizo, Ario Takeuchi, Momoe Itsumi, Junichi Inokuchi, Katsunori Tatsugami, Takeshi
Uchiumi, and Seiji Naito
European Journal of Cancer
(2015)
51 :1962
-
Dissecting Major Signaling Pathways throughout the Development of Prostate Cancer
Henrique B. da Silva, Eduardo P. Amaral, Eduardo L. Nolasco, Nathalia C. de Victo, Rodrigo Atique, Carina C. Jank, Valesca
Anschau, Luiz F. Zerbini, and Ricardo G. Correa
Prostate Cancer
(2013)
2013 :1
-
Ankyrin G expression is associated with androgen receptor stability, invasiveness, and lethal outcome in prostate cancer patients
Tingting Wang, Hatem Abou-Ouf, Samar A. Hegazy, Mohammed Alshalalfa, Konstantin Stoletov, John Lewis, Bryan Donnelly, and
Tarek A. Bismar
Journal of Molecular Medicine
(2016)
94 :1411
-
Methyltransferase Inhibitor Adenosine Dialdehyde Suppresses Androgen Receptor Expression and Prostate Cancer Growth
Masaki Shiota, Ario Takeuchi, Akira Yokomizo, Eiji Kashiwagi, Katsunori Tatsugami, and Seiji Naito
The Journal of Urology
(2012)
188 :300
-
Chemotherapy and Targeted Therapies: Are We Making Progress in Castrate-Resistant Prostate Cancer?
Jean Hoffman-Censits and Maofu Fu
Seminars in Oncology
(2013)
40 :361
-
Differential expression of AP-1 transcription factors in human prostate LNCaP and PC-3 cells: role of Fra-1 in transition
to CRPC status
K. Kavya, M. Naveen Kumar, Rajeshwari H. Patil, Shubha M. Hegde, K. M. Kiran Kumar, Rashmi Nagesh, R. L. Babu, Govindarajan
T. Ramesh, and S. Chidananda Sharma
Molecular and Cellular Biochemistry
(2017)
:
-
Investigational serine/threonine kinase inhibitors against prostate cancer metastases
Claudio Festuccia
Expert Opinion on Investigational Drugs
(2017)
26 :25
-
Dissecting major signaling pathways in prostate cancer development and progression: Mechanisms and novel therapeutic targets
Senthilmurugan Ramalingam, Vidya P. Ramamurthy, and Vincent C.O. Njar
The Journal of Steroid Biochemistry and Molecular Biology
(2017)
166 :16
-
What is the pathophysiology of a hormone-resistant prostate tumour?
Bertrand Tombal
European Journal of Cancer
(2011)
47 :S179
-
Enzalutamide: looking back at its preclinical discovery
Yun-Sok Ha and Isaac Yi Kim
Expert Opinion on Drug Discovery
(2014)
9 :837
-
Aldo–Keto Reductase AKR1C1–AKR1C4: Functions, Regulation, and Intervention for Anti-cancer Therapy
Chen-Ming Zeng, Lin-Lin Chang, Mei-Dan Ying, Ji Cao, Qiao-Jun He, Hong Zhu, and Bo Yang
Frontiers in Pharmacology
(2017)
8 :
-
Expression and Functional Role of Orphan Receptor GPR158 in Prostate Cancer Growth and Progression
Nitin Patel, Tatsuo Itakura, Shinwu Jeong, Chun-Peng Liao, Pradip Roy-Burman, Ebrahim Zandi, Susan Groshen, Jacek Pinski,
Gerhard A. Coetzee, Mitchell E. Gross, M. Elizabeth Fini, and Craig N Robson
PLOS ONE
(2015)
10 :e0117758
-
SMYD3 as an Oncogenic Driver in Prostate Cancer by Stimulation of Androgen Receptor Transcription
C. Liu, C. Wang, K. Wang, L. Liu, Q. Shen, K. Yan, X. Sun, J. Chen, J. Liu, H. Ren, H. Liu, Z. Xu, S. Hu, D. Xu, and Y. Fan
JNCI Journal of the National Cancer Institute
(2013)
105 :1719
-
Quantitative analysis of castration resistant prostate cancer progression through phosphoproteome signaling
Reynald M Lescarbeau and David L Kaplan
BMC Cancer
(2014)
14 :
-
Negative Regulation of the Androgen Receptor Gene Through a Primate-Specific Androgen Response Element Present in the 5′ UTR
Colin W. Hay, Kate Watt, Irene Hunter, Derek N. Lavery, Alasdair MacKenzie, and Iain J. McEwan
Hormones and Cancer
(2014)
5 :299
-
Osteopontin-c mediates the upregulation of androgen responsive genes in LNCaP cells through PI3K/Akt and androgen receptor
signaling
Tatiana Tilli, Luciana Ferreira, and Etel Gimba
Oncology Letters
(2015)
:
-
Experimental Evidence of Persistent Androgen-Receptor-Dependency in Castration-Resistant Prostate Cancer
Takashi Kobayashi, Takahiro Inoue, Tomomi Kamba, and Osamu Ogawa
International Journal of Molecular Sciences
(2013)
14 :15615
-
PMA induces androgen receptor downregulation and cellular apoptosis in prostate cancer cells
M. Itsumi, M. Shiota, A. Yokomizo, A. Takeuchi, E. Kashiwagi, T. Dejima, J. Inokuchi, K. Tatsugami, T. Uchiumi, and S. Naito
Journal of Molecular Endocrinology
(2014)
53 :31
-
The prognostic significance of combined ERG and androgen receptor expression in patients with prostate cancer managed by androgen
deprivation therapy
Kuo-Cheng Huang, Mohammed Alshalalfa, Samar A Hegazy, Michael Dolph, Bryan Donnelly, and Tarek A Bismar
Cancer Biology & Therapy
(2014)
15 :1120
-
Low systemic testosterone levels induce androgen maintenance in benign rat prostate tissue
Y. Zhou, M. Otto-Duessel, M. He, S. Markel, T. Synold, and J. O. Jones
Journal of Molecular Endocrinology
(2013)
51 :143
-
Increased androgen receptor gene copy number is associated withTMPRSS2-ERGrearrangement in prostatic small cell carcinoma
Lisha Wang, Sean R. Williamson, Shaobo Zhang, Jiaoti Huang, Rodolfo Montironi, Darrell D. Davison, Mingsheng Wang, Jorge L.
Yao, Antonio Lopez-Beltran, Adeboye O. Osunkoya, Gregory T. MacLennan, Lee Ann Baldridge, Xiang Du, and Liang Cheng
Molecular Carcinogenesis
(2015)
54 :900
-
EP2 signaling mediates suppressive effects of celecoxib on androgen receptor expression and cell proliferation in prostate
cancer
E Kashiwagi, M Shiota, A Yokomizo, J Inokuchi, T Uchiumi, and S Naito
Prostate Cancer and Prostatic Disease
(2014)
17 :10
-
Prostaglandin receptor EP3 mediates growth inhibitory effect of aspirin through androgen receptor and contributes to castration
resistance in prostate cancer cells
E. Kashiwagi, M. Shiota, A. Yokomizo, M. Itsumi, J. Inokuchi, T. Uchiumi, and S. Naito
Endocrine Related Cancer
(2013)
20 :431
-
Pro-survival and anti-apoptotic properties of androgen receptor signaling by oxidative stress promote treatment resistance
in prostate cancer
M. Shiota, A. Yokomizo, and S. Naito
Endocrine Related Cancer
(2012)
19 :R243
-
Targeted Prodrug Approaches for Hormone Refractory Prostate Cancer
Herve Aloysius and Longqin Hu
Medicinal Research Reviews
(2015)
35 :554
-
Development of enzalutamide for metastatic castration-resistant prostate cancer
Suman Bhattacharya, Mohammad Hirmand, De Phung, and Steve van Os
Annals of the New York Academy of Sciences
(2015)
1358 :13
-
Protein kinase C regulates Twist1 expression via NF-κB in prostate cancer
Masaki Shiota, Akira Yokomizo, Ario Takeuchi, Eiji Kashiwagi, Takashi Dejima, Junichi Inokuchi, Katsunori Tatsugami, Takeshi
Uchiumi, and Masatoshi Eto
Endocrine-Related Cancer
(2017)
24 :171
-
Preparation of Nanobubbles Carrying Androgen Receptor siRNA and Their Inhibitory Effects on Androgen-Independent Prostate
Cancer when Combined with Ultrasonic Irradiation
Luofu Wang, Miao Zhang, Kaibin Tan, Yanli Guo, Haipeng Tong, Xiaozhou Fan, Kejing Fang, Rui Li, and Zoran Culig
PLoS ONE
(2014)
9 :e96586
-
Low Testosterone Alters the Activity of Mouse Prostate Stem Cells
Ye Zhou, Ben Copeland, Maya Otto-Duessel, Miaoling He, Susan Markel, Tim W. Synold, and Jeremy O. Jones
The Prostate
(2017)
77 :530
-
Oxidative stress and androgen receptor signaling in the development and progression of castration-resistant prostate cancer
Masaki Shiota, Akira Yokomizo, and Seiji Naito
Free Radical Biology and Medicine
(2011)
51 :1320
-
Inhibition of RSK/YB-1 signaling enhances the anti-cancer effect of enzalutamide in prostate cancer
Masaki Shiota, Akira Yokomizo, Ario Takeuchi, Momoe Itsumi, Kenjiro Imada, Eiji Kashiwagi, Junichi Inokuchi, Katsunori Tatsugami,
Takeshi Uchiumi, and Seiji Naito
The Prostate
(2014)
74 :959
-
Downregulation of Androgen Receptor Transcription by Promoter G-Quadruplex Stabilization as a Potential Alternative Treatment
for Castrate-Resistant Prostate Cancer
Tom Mitchell, Antonio Ramos-Montoya, Marco Di Antonio, Pierre Murat, Stephan Ohnmacht, Marialuisa Micco, Sarah Jurmeister,
Lee Fryer, Shankar Balasubramanian, Stephen Neidle, and David E. Neal
Biochemistry
(2013)
52 :1429
-
MicroRNA-185 suppresses proliferation, invasion, migration, and tumorigenicity of human prostate cancer cells through targeting
androgen receptor
Fajun Qu, Xingang Cui, Yi Hong, Junkai Wang, Yao Li, Lu Chen, Yushan Liu, Yi Gao, Danfeng Xu, and Quanxing Wang
Molecular and Cellular Biochemistry
(2013)
377 :121
-
Changes of protein expression in prostate cancer having lost its androgen sensitivity
Gergely Bánfi, Ivett Teleki, Péter Nyirády, Attila Keszthelyi, Imre Romics, Attila Fintha, Tibor Krenács, and Béla Szende
International Urology and Nephrology
(2015)
47 :1149
-
Efficacy of androgen deprivation therapy and the role of oxidative stress
D. K. Price
Annals of Oncology
(2017)
28 :451
-
Enzalutamide, an androgen receptor signaling inhibitor, induces tumor regression in a mouse model of castration-resistant
prostate cancer
Javier Guerrero, Iván E. Alfaro, Francisco Gómez, Andrew A. Protter, and Sebastián Bernales
The Prostate
(2013)
73 :1291
